Biolargo Inc

Greetings. Welcome to the BioLargo second quarter 2023 earning results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note, this conference is being recorded. I will now turn the conference over to your host, Brian Loper. You may begin.

Thank you, John. Good afternoon, everyone, and welcome to BioLargo's Q2 2023 quarterly results conference call. By now, everyone should have had access to the earnings press release, which was issued yesterday prior to market open, and the 10Q report filed at the SEC. This call is being webcast and is available for replay. In our remarks today, we may include statements that are considered forward-looking within the meanings of securities laws, including forward-looking statements about future results of operations, business strategies and plans, our relationships with our customers, market and potential growth opportunities. In addition, management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current knowledge and expectations as of today and are subject to certain risks and uncertainties and may cause the actual results to differ materially from the forward-looking statements. A detailed discussion of such risks and uncertainties are contained in our most recent form 10Q, 10K, and other reports filed at the SEC. The company undertakes no obligation to update any forward-looking statements. And with that, I now hand the call over to BioLogger's Chief Executive Officer, Dennis Calvert.

Hey, Brian. Thank you very much. This is Dennis Calvert. I appreciate everyone joining us today. And as usual, we've got a lot to share, so we're going to plow through a lot of information quickly. And again, it's our privilege to have the chance to talk to you today So BioLargo, we make life better, sustainable innovation focused on making a better clean air, clean water, cleaner earth, making life better across a number of fields as an innovator and solution provider. Our strategy is pretty basic, invent it, prove it, and partner it. And we have got multiple platform technologies in cycle with a couple of commercial endeavors under our belt and more coming. So we're going to highlight those today. We've already covered the safe harbor statement by Brian. Thank you very much for that, Brian. Part of our messaging is very important. You know, who are we? What are we doing? Well, we're science and engineers, entrepreneurs, passionate about making a difference in health and sustainability, focus on a mission of making life better. How do we do that? We focus on best in class. It's very important. Best in class solutions. with engineering-forward technologies, heavy science, heavy engineering, focused on solutions without, problems without good solutions. That's the emphasis of the company, and we got a number that are really significant in terms of making a high impact, impact-driven company. This is a pretty new slide. You know, we often ask the question, you got so much going on, how do you explain it in one shot? Well, this is an attempt. This is an attempt. You'll have to study. I'm not gonna go through all the words, Really, if you think about it, the parent company is focused on finance and strategy. The engineering group supports all of the operating units and innovators. The water company is primarily focused on R&D. The engineering company does have some clients while we're building support for our technologies and commercial endeavors. And now, as a result of all this innovation, putting this together for a commercial assault, we have four commercial operating entities. Clear, of course, we've talked about BioLargo Energy, a new subsidiary with a new battery technology in development, not yet commercial. O&M Environmental, where all our odor and VOC control products are housed, been commercial now well over eight years, and now breaking records. And then, of course, this new enterprise called BioLargo Equipment, Science, and Technology. Colloquially, we would say best. The best equipment, focused with an emphasis on PFAS but also the entire catalog of technologies and solutions focused on primarily the water industry. And so this is a nice way to think about the company, an innovation engine with resources to support the development, the commercialization, and ultimately the exit, the exit, focused on either spin-out, merger and acquisition, or licensure.